Investors & Media

Company Overview

UNITY Biotechnology is developing therapeutics to slow, halt or reverse diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as ophthalmologic and neurologic diseases.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Latest Presentation